1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow You Lu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC Low-dose radiotherapy, Durvalumab, Etoposide, and cisplatin/carboplatin - Lung Cancer, Extensive-stage Small-cell Lung Cancer | Phase 2 | Active not recruiting | You Lu | 30 | 2022-03-02 | 2026-05-08 |
Lung Neoplasms (1) · Small Cell Lung Carcinoma (1)
Carboplatin (1) · Cisplatin (1) · Etoposide (1) · Radiotherapy (1) · durvalumab (1)
China (1)
Lu Lu Su, MD (1) · Shu Jie Li, MM (1) · Shun Dong Cang, MD (1) · Yan Zhang, MD (1) · Yue Xie, MM (1)